CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Performance Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2026-09-23 | Borges David J. VP, Finance & CAO | Option exercise 10b5-1 | +10,000 | $15.58 | $156K | 10,000 |
| 2026-09-23 | Borges David J. VP, Finance & CAO | Sale 10b5-1 | −10,000 | $20.95 | $210K | 0 |
| 2026-09-23 | Borges David J. VP, Finance & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 5,000 | ||
| 2026-09-22 | Borges David J. VP, Finance & CAO | Option exercise 10b5-1 | +5,000 | $3.93 | $20K | 5,000 |
| 2026-09-22 | Borges David J. VP, Finance & CAO | Option exercise 10b5-1 | +5,000 | $2.94 | $15K | 10,000 |
| 2026-09-22 | Borges David J. VP, Finance & CAO | Sale 10b5-1 | −10,000 | $20.95 | $210K | 0 |
| 2026-09-22 | Borges David J. VP, Finance & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 4,094 | ||
| 2026-09-22 | Borges David J. VP, Finance & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | ||
| 2026-08-31 | Cancelmo Peter B VP, General Counsel | Option exercise | +25,000 | $2.94 | $74K | 25,200 |
| 2026-08-31 | Cancelmo Peter B VP, General Counsel | Sale | −25,000 | $18.54 | $464K | 200 |
| 2026-08-31 | Cancelmo Peter B VP, General Counsel | Option exercise · Stock Option (Right to Buy) | −25,000 | 50,000 | ||
| 2026-08-28 | Cancelmo Peter B VP, General Counsel | Option exercise | +25,000 | $2.94 | $74K | 25,200 |
| 2026-08-28 | Cancelmo Peter B VP, General Counsel | Sale | −25,000 | $18.65 | $466K | 200 |
| 2026-08-28 | Cancelmo Peter B VP, General Counsel | Option exercise · Stock Option (Right to Buy) | −25,000 | 75,000 | ||
| 2026-08-27 | HANISH ARNOLD C Director | Option exercise | +2,500 | $15.81 | $40K | 2,500 |
| 2026-08-27 | HANISH ARNOLD C Director | Option exercise | +7,500 | $14.66 | $110K | 10,000 |
| 2026-08-27 | HANISH ARNOLD C Director | Sale | −5,000 | $18.88 | $94K | 5,000 |
| 2026-08-27 | HANISH ARNOLD C Director | Sale | −5,000 | $19.02 | $95K | 0 |
| 2026-08-27 | HANISH ARNOLD C Director | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 |
Page 1 of 9 · 178 trades